{
    "organizations": [],
    "uuid": "68332753f90b19b79a4b2bf5fe2887d52cb0ccca",
    "author": "",
    "url": "https://www.reuters.com/article/brief-durect-announces-amendment-to-lice/brief-durect-announces-amendment-to-licensing-agreement-with-sandoz-idUSFWN1SG0U9",
    "ord_in_thread": 0,
    "title": "BRIEF-Durect Announces Amendment To Licensing Agreement With Sandoz",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9, 2018 / 12:07 PM / in 10 minutes BRIEF-Durect Announces Amendment To Licensing Agreement With Sandoz Reuters Staff\nMay 9 (Reuters) - DURECT Corp:\n* DURECT ANNOUNCES AMENDMENT TO LICENSING AGREEMENT WITH SANDOZ RELATED TO POSIMIR® (SABER®-BUPIVACAINE)\n* DURECT CORP - DURECT IS NOW ELIGIBLE FOR UP TO $30 MILLION IN MILESTONE PAYMENTS BASED ON NDA APPROVAL\n* DURECT CORP - EACH PARTY, PURSUANT TO AMENDMENT, IS ALSO PERMITTED TO DEVELOP OR COMMERCIALIZE COMPETING PRODUCTS\n* DURECT CORP - PURSUANT TO AMENDED AGREEMENT, DURECT REMAINS ELIGIBLE FOR UP TO AN ADDITIONAL $230 MILLION IN SALES-BASED MILESTONES\n* DURECT - PURSUANT TO AMENDED AGREEMENT, THERE IS NEW TERMINATION FEE PAYABLE TO DURECT IN EVENT THAT SANDOZ TERMINATES AGREEMENT FOR CONVENIENCE\n* DURECT CORP - AMENDMENT ALSO INCLUDES MODIFICATIONS TO DURECT’S DEVELOPMENT OBLIGATIONS AND TO BOTH PARTIES’ TERMINATION PROVISIONS\n* DURECT CORP - DURECT HAS RIGHT TO TERMINATE FOR CONVENIENCE PRIOR TO NDA APPROVAL Source text for Eikon: Further company coverage:",
    "published": "2018-05-09T15:05:00.000+03:00",
    "crawled": "2018-05-09T15:21:09.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "pm",
        "minute",
        "announces",
        "amendment",
        "licensing",
        "agreement",
        "sandoz",
        "reuters",
        "staff",
        "may",
        "reuters",
        "durect",
        "corp",
        "durect",
        "announces",
        "amendment",
        "licensing",
        "agreement",
        "sandoz",
        "related",
        "durect",
        "corp",
        "durect",
        "eligible",
        "million",
        "milestone",
        "payment",
        "based",
        "nda",
        "approval",
        "durect",
        "corp",
        "party",
        "pursuant",
        "amendment",
        "also",
        "permitted",
        "develop",
        "commercialize",
        "competing",
        "product",
        "durect",
        "corp",
        "pursuant",
        "amended",
        "agreement",
        "durect",
        "remains",
        "eligible",
        "additional",
        "million",
        "milestone",
        "durect",
        "pursuant",
        "amended",
        "agreement",
        "new",
        "termination",
        "fee",
        "payable",
        "durect",
        "event",
        "sandoz",
        "terminates",
        "agreement",
        "convenience",
        "durect",
        "corp",
        "amendment",
        "also",
        "includes",
        "modification",
        "durect",
        "development",
        "obligation",
        "party",
        "termination",
        "provision",
        "durect",
        "corp",
        "durect",
        "right",
        "terminate",
        "convenience",
        "prior",
        "nda",
        "approval",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}